New drug trial aims to tackle high heart disease risk in black community
NCT ID NCT06320951
Summary
This study is testing whether a drug called vericiguat can improve heart and metabolic health in Black adults with obesity and insulin resistance. Researchers will enroll 200 participants to take either the drug or a placebo pill daily for 12 weeks. The main goals are to see if the drug improves how the body uses insulin and burns energy, which could help control related diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.